BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12664928)

  • 1. [Case of polycystic lung disease with mixed infections due to Aspergillus and Mycobacterium fortuitum successfully treated by AZM].
    Ito N; Kudo S
    Jpn J Antibiot; 2002 Dec; 55(6):893-7. PubMed ID: 12664928
    [No Abstract]   [Full Text] [Related]  

  • 2. [Case of chronic necrotizing pulmonary aspergillosis successfully treated with a combination of liposomal amphotericin B and itraconazole].
    Kiyokawa H; Nakashima R; Takafuji S; Suzuki Y; Ito A
    Nihon Kokyuki Gakkai Zasshi; 2008 Jun; 46(6):448-54. PubMed ID: 18592989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Four cases of pulmonary aspergilloma successfully treated with drug therapy].
    Kawana A
    Jpn J Antibiot; 2000 Feb; 53(2):91-100; discussion 100-2. PubMed ID: 10896541
    [No Abstract]   [Full Text] [Related]  

  • 4. [Case of pulmonary aspergillosis successfully treated with itraconazole].
    Watanabe T; Kuriyama K; Kamei K
    Jpn J Antibiot; 2000 Feb; 53(2):103-6; discussion 106-7. PubMed ID: 10896537
    [No Abstract]   [Full Text] [Related]  

  • 5. [Two cases of pulmonary aspergillosis successfully treated with multidrug therapy].
    Anndo T
    Jpn J Antibiot; 2000 Feb; 53(2):84-90; dicussion 90. PubMed ID: 10896540
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chronic necrotizing pulmonary aspergillosis treated with itraconazole and inhaled amphotericin B].
    Sato A; Nakatani K; Matsushita Y; Matsuo H; Yamadori H; Kurasawa T; Ikeda Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Oct; 33(10):1141-5. PubMed ID: 8544389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.
    Chandrasekar PH; Cutright JL; Manavathu EK
    Clin Microbiol Infect; 2004 Oct; 10(10):925-8. PubMed ID: 15373889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral pulmonary aspergilloma in ankylosing spondylitis treated with transthoracic intracavitary instillations of antifungal agents.
    Stiksa G; Eklundh G; Riebe I; Simonsson BG
    Scand J Respir Dis; 1976; 57(4):163-70. PubMed ID: 790560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination therapy of micafungin and itraconazole for a case of pulmonary aspergillosis].
    Maruyama T; Takagi T; Yuda H
    Nihon Kokyuki Gakkai Zasshi; 2005 Feb; 43(2):94-8. PubMed ID: 15770940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of SCH51048 in an experimental model of pulmonary aspergillosis.
    Allendoerfer R; Loebenberg D; Rinaldi MG; Graybill JR
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1345-8. PubMed ID: 7574528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of nebulized liposomal amphotericin B in treatment of experimental pulmonary aspergillosis.
    Gavaldà J; Martín MT; López P; Gomis X; Ramírez JL; Rodríguez D; Len O; Puigfel Y; Ruíz I; Pahissa A
    Antimicrob Agents Chemother; 2005 Jul; 49(7):3028-30. PubMed ID: 15980392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo resistance of a laboratory-selected Aspergillus fumigatus isolate to amphotericin B.
    Manavathu EK; Cutright JL; Chandrasekar PH
    Antimicrob Agents Chemother; 2005 Jan; 49(1):428-30. PubMed ID: 15616327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features of pulmonary disease caused by Mycobacterium fortuitum].
    Hagiwara E; Sekine A; Sato T; Baba T; Shinohara T; Endo T; Sogo Y; Nishihira R; Komatsu S; Matsumoto Y; Ogura T; Takahashi H
    Nihon Kokyuki Gakkai Zasshi; 2008 Oct; 46(10):788-92. PubMed ID: 19044027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel cause of invasive pulmonary infection in an immunocompetent patient: Aspergillus candidus.
    Ribeiro SC; Santana AN; Arriagada GH; Martins JE; Takagaki TY
    J Infect; 2005 Nov; 51(4):e195-7. PubMed ID: 16291268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nebulized amphotericin B combined with intravenous amphotericin B in rats with severe invasive pulmonary aspergillosis.
    Ruijgrok EJ; Fens MH; Bakker-Woudenberg IA; van Etten EW; Vulto AG
    Antimicrob Agents Chemother; 2006 May; 50(5):1852-4. PubMed ID: 16641459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disseminated invasive aspergillosis in an apparently immunocompetent host.
    Raja NS; Singh NN
    J Microbiol Immunol Infect; 2006 Feb; 39(1):73-7. PubMed ID: 16440127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of direct infusion of antifungal agent on invasive pulmonary aspergillosis in a patient with acute leukemia.
    Nakase K; Yazaki A; Tamaki S; Tanigawa M; Tsuji K; Miyanishi E; Shiku H
    J Infect Chemother; 2002 Mar; 8(1):106-8. PubMed ID: 11957130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal prophylaxis is effective against murine invasive pulmonary aspergillosis.
    Rieg G; Spellberg B; Schwartz J; Fu Y; Edwards JE; Sheppard DC; Ibrahim AS
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2895-6. PubMed ID: 16870798
    [No Abstract]   [Full Text] [Related]  

  • 19. SCH56592 treatment of murine invasive aspergillosis.
    Graybill JR; Bocanegra R; Najvar LK; Luther MF; Loebenberg D
    J Antimicrob Chemother; 1998 Oct; 42(4):539-42. PubMed ID: 9818757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of nebulised liposomal amphotericin B in the treatment of Aspergillus fumigatus empyema.
    Purcell IF; Corris PA
    Thorax; 1995 Dec; 50(12):1321-3. PubMed ID: 8553311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.